Tirzepatide is an increasingly popular injectable medication used to help overweight and obese individuals lose significant quantities of weight
refrigeration is recommended for extended shelf life
The dose is too low for metabolic effects, and the anti-inflammatory effects are building but not yet clinically apparent
Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s for Sustained Weight Loss Company builds on nearly 10 years of GLP-1 experience, expanding its Sustainable Weight Loss solution to deliver medication-free and medication-assisted weight loss Virta Health has released first-of-its-kind, peer-reviewed data demonstrating the companys approach to personalized nutrition therapy results in sustained weight loss after the discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1s), including Ozempic
[13] Wharton S, Haase CL, Kamran E, Liu A, Mancini J, Neish D, Pakseresht A, Power GS, Christensen RAG
Estos resultados conllevarn, sin duda, la inclusin de estos frmacos en el algoritmo de tratamiento de las personas con AOS y obesidad de manera coadyuvante a los cambios del estilo de vida